Physician profile
Corey Snyder
NPI 1417571209
$797.40
in general payments reported to CMS, 2019-2025
16 companies · $204 in 2025
The $204 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $233 · 2024: $360 · 2025: $204.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $797.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $797.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $217.57 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Ethicon US, LLC | $116.02 | 2023 | Echelon; Endopath |
| Bayer Healthcare Pharmaceuticals INC. | $82.67 | 2023-2024 | |
| Abbvie INC. | $81.90 | 2023-2025 | Ubrelvy |
| Lilly USA, LLC | $55.59 | 2023-2024 | Mounjaro, Jardiance |
| Axsome Therapeutics, INC. | $55.33 | 2024-2025 | Auvelity, Symbravo |
| Amgen INC. | $29.24 | 2024-2025 | Otezla, Repatha, Otezla |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $23.42 | 2025 | Xifaxan |
| Phathom Pharmaceuticals, INC. | $21.51 | 2024 | Voquezna |
| Astrazeneca Pharmaceuticals LP | $19.72 | 2024 | Breztri |
| Exact Sciences Corporation | $19.25 | 2023 | Cologuard Collection Kit |
| Corcept Therapeutics | $18.56 | 2025 | Korlym |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $18.25 | 2024 | Caplyta |
| Janssen Pharmaceuticals, INC | $15.15 | 2023 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.11 | 2023 | Jardiance |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $8.11 | 2024 | Azstarys |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Corey Snyder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.